Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Dr. Joseph A. Miller
On January 11, 2022, Dr. Joseph A. Miller tendered his resignation as a director
of Lightwave Logic, Inc. (the "Company") to the Company's Board of Directors
(the "Board") effective January 17, 2022. Dr. Miller's resignation is not a
result of any disagreement between himself and the Company, its management, the
Board or any committee of the Board. A copy of Dr. Miller's letter of
resignation is attached as Exhibit 17.1 hereto.
Appointment of Dr. Craig Ciesla
On January 17, 2022, the Board elected Dr. Craig Ciesla to serve as a member of
the Board. Dr. Ciesla's initial term as a Class II member of the Board will
continue until the Company's 2022 Annual Meeting of Shareholders or until his
successor is duly appointed.
Dr. Ciesla is currently the Vice President, Head of the Advanced Platforms and
Devices Group at Illumina, a leading provider of DNA sequencing and array
technologies. There he leads a team driving innovation in sequencing platforms,
microfluidics, electronics, and nanofabrication. He has held this position since
June 2017. Prior to Illumina, from June 2016 to June 2017, he was Vice President
of Engineering at Kaiam, where he was responsible for the development and
production of 100G transceivers for the data-center market. He was also the
founding CEO of Tactus Technology, an innovator in the user interface industry,
where he was the co-inventor of Tactus' polymer morphing screen technology.
Before Tactus he had a variety of roles at Intel, JDSU (now Lumentum), Bookham
(now Oclaro) and Ignis Optics developing a wide range of products in the
fiber-optics market. He started his career at Toshiba Research Europe, where he
performed early terahertz images of skin cancer. Dr. Ciesla holds a BSc (Hons.)
in Applied Physics and Ph.D. in Physics from Heriot-Watt University in
Edinburgh.
Dr. Ciesla has been named to serve on the Audit Committee and the Nominating and
Corporate Governance Committee of the Board.
Dr. Ciesla will receive the following compensation for serving as a director:
$30,000 annual cash fee paid quarterly at the end of each quarter, $50,000 RSAs
vesting annually over 3 years, 50,000 options vesting monthly over one year.
Item 8.01 Other Events.
Press Release
On January 18, 2022, the Company issued a press release announcing the election
of Dr. Craig Ciesla as a member of the Board. A copy of the press release is
attached as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit
No. Description
17.1 Resignation Letter - Dr. Joseph A. Miller
99.1 Press Release - January 18, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses
LIGHTWAVE LOGIC, INC. 
